Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US

Rhea-AI Summary

Senzime (OTCQX:SNZZF) announced that its TetraGraph System was added to agreements with Vizient, Premier, and HealthTrust Performance Group on April 24, 2026. These three GPOs serve roughly 95% of US hospitals and have combined annual purchasing volumes exceeding USD 200 billion. The company said GPO listings remove procurement barriers, may shorten sales cycles with pre-negotiated pricing, and could help convert pipeline opportunities into orders, supporting broader US commercial expansion over time.

AI-generated analysis. Not financial advice.

Positive

• Listed with three leading US GPOs (Vizient, Premier, HealthTrust)
• Access to >5,000 hospitals affiliated with at least one GPO
• Exposure to USD 200B combined annual purchasing volume

Negative

• GPO listings do not generate immediate revenue and require conversion to orders
• No contract values or guaranteed purchase commitments disclosed
• Commercial impact is conditional on shortening sales cycles and converting pipeline

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that the TetraGraph System has secured inclusion in agreements with Vizient, Premier, and HealthTrust Performance Group, the three leading US Group Purchasing Organizations (GPOs). Approximately 95% of US hospitals engage with GPOs to support procurement processes, and these listings have the potential to expand and accelerate Senzime's market reach.

"Inclusion in all three major US GPO catalogues marks an important step in our commercial expansion. While GPO listings do not in themselves generate immediate revenues, they remove structural barriers in the US procurement process and significantly improve our ability to convert existing pipeline opportunities into orders," commented Philip Siberg, CEO of Senzime. "With pre-negotiated pricing and processes in place, this has the potential to shorten sales cycles and increase the scalability of our commercial efforts. This creates a strong foundation for broader adoption over time, including the potential for additional system-wide agreements with hospital networks."

More than 5,000 US hospitals are affiliated with at least one GPO to manage procurement of qualified products. Vizient, Premier Inc., and HealthTrust Performance Group are the three leading medical device GPOs in the US, with combined annual purchasing volumes exceeding USD 200 billion.

For further information, please contact:

Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com

About Senzime

Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies. Established in 1999, Senzime develops and markets precision-based monitoring systems that improve outcomes, reduce costs, and advance perioperative patient safety. The flagship solution is the TetraGraph® system, proven best-in-class for accurate monitoring of neuromuscular transmission during surgery and used in thousands of operating rooms across the globe. The system helps to secure precise dosing of paralytic drugs and provides enhanced insights to safeguard every patient's journey, from anesthesia to recovery.

Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the US OTCQX Market (SNZZF), and backed by long-term investors. More information is available at senzime.com.

Image Attachments

TetraGraph System

Attachments

Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US

SOURCE: Senzime

View the original press release on ACCESS Newswire

FAQ

What did Senzime (SNZZF) announce on April 24, 2026 about GPO listings?

Senzime announced TetraGraph was included in Vizient, Premier, and HealthTrust GPO agreements. According to the company, these listings remove procurement barriers and may shorten sales cycles, improving ability to convert pipeline opportunities into orders over time.

How many US hospitals could Senzime reach through the GPO agreements for SNZZF?

More than 5,000 US hospitals are affiliated with at least one GPO. According to the company, about 95% of US hospitals engage with GPOs, so listings expand the addressable procurement channels for TetraGraph.

Does the Vizient/Premier/HealthTrust listing mean immediate revenue for SNZZF?

No — GPO inclusion does not create immediate sales. According to the company, listings remove structural procurement barriers but require conversion of pipeline opportunities into orders to generate revenue.

What is the financial scale of purchasing through the three GPOs listed for SNZZF?

The three GPOs have combined annual purchasing volumes exceeding USD 200 billion. According to the company, that scale reflects the potential market reach but not guaranteed purchases for TetraGraph.

How might the GPO listings affect Senzime's US sales process for SNZZF?

Listings may shorten sales cycles and standardize pricing and procurement processes. According to the company, pre-negotiated pricing and processes could improve scalability and aid conversion of existing pipeline opportunities into orders.